A Fully-Automatic Framework for Parkinson's Disease Diagnosis by Multi-Modality Images

Background: Parkinson's disease (PD) is a prevalent long-term neurodegenerative disease. Though the diagnostic criteria of PD are relatively well defined, the current medical imaging diagnostic procedures are expertise-demanding, and thus call for a higher-integrated AI-based diagnostic algorithm. Methods: In this paper, we proposed an automatic, end-to-end, multi-modality diagnosis framework, including segmentation, registration, feature generation and machine learning, to process the information of the striatum for the diagnosis of PD. Multiple modalities, including T1- weighted MRI and 11C-CFT PET, were used in the proposed framework. The reliability of this framework was then validated on a dataset from the PET center of Huashan Hospital, as the dataset contains paired T1-MRI and CFT-PET images of 18 Normal (NL) subjects and 49 PD subjects. Results: We obtained an accuracy of 100% for the PD/NL classification task, besides, we conducted several comparative experiments to validate the diagnosis ability of our framework. Conclusion: Through experiment we illustrate that (1) automatic segmentation has the same classification effect as the manual segmentation, (2) the multi-modality images generates a better prediction than single modality images, and (3) volume feature is shown to be irrelevant to PD diagnosis.

Learning Optimal Deep Projection of $^{18}$F-FDG PET Imaging for Early Differential Diagnosis of Parkinsonian Syndromes

Several diseases of parkinsonian syndromes present similar symptoms at early stage and no objective widely used diagnostic methods have been approved until now. Positron emission tomography (PET) with $^{18}$F-FDG was shown to be able to assess early neuronal dysfunction of synucleinopathies and tauopathies. Tensor factorization (TF) based approaches have been applied to identify characteristic metabolic patterns for differential diagnosis. However, these conventional dimension-reduction strategies assume linear or multi-linear relationships inside data, and are therefore insufficient to distinguish nonlinear metabolic differences between various parkinsonian syndromes. In this paper, we propose a Deep Projection Neural Network (DPNN) to identify characteristic metabolic pattern for early differential diagnosis of parkinsonian syndromes. We draw our inspiration from the existing TF methods. The network consists of a (i) compression part: which uses a deep network to learn optimal 2D projections of 3D scans, and a (ii) classification part: which maps the 2D projections to labels. The compression part can be pre-trained using surplus unlabelled datasets. Also, as the classification part operates on these 2D projections, it can be trained end-to-end effectively with limited labelled data, in contrast to 3D approaches. We show that DPNN is more effective in comparison to existing state-of-the-art and plausible baselines.